Spruce Biosciences, Inc. Proceeds from Issuance of Redeemable Convertible Preferred Stock
Spruce Biosciences, Inc. (SPRB) reported Proceeds from Issuance of Redeemable Convertible Preferred Stock of $87.63 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock · last filed 2021-11-15
- Spruce Biosciences, Inc. proceeds from issuance of redeemable convertible preferred stock for the quarter ending 2020-09-30 was $43.98M.
- Spruce Biosciences, Inc. proceeds from issuance of redeemable convertible preferred stock for the quarter ending 2020-06-30 was -$7.00K.
- Spruce Biosciences, Inc. proceeds from issuance of redeemable convertible preferred stock for the quarter ending 2020-03-31 was $43.66M.
| Period end | Proceeds from Issuance of Redeemable Convertible Preferred Stock 3 month | Proceeds from Issuance of Redeemable Convertible Preferred Stock 6 month | Proceeds from Issuance of Redeemable Convertible Preferred Stock 9 month |
|---|---|---|---|
| 2020-09-30 | $43.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $43.98M derived: sum of 2 quarters · filed 2021-11-15 | $87.63M 10-Q · filed 2021-11-15 |
| 2020-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $43.65M 10-Q · filed 2021-08-10 | |
| 2020-03-31 | $43.66M 10-Q · filed 2021-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |